Showing results (61-70 of 386) with videos related to

Sort By:
Pageof 39
STAR Protocols|October 28, 2020
High-Throughput Mass Cytometry Staining for Immunophenotyping Clinical SamplesEmily M Thrash, Katja Kleinsteuber, Emma S Hathaway, et al.
Expert Review of Anticancer Therapy|November 13, 2015
Clinical development of talimogene laherparepvec (T-VEC): a modified herpes simplex virus type-1-derived oncolytic immunotherapyKevin J Harrington, Igor Puzanov, J Randolph Hecht, et al.
Cancer Immunology, Immunotherapy : CII|September 8, 2018
Management of metastatic melanoma: improved survival in a national cohort following the approvals of checkpoint blockade immunotherapies and targeted therapiesAllison S Dobry, Cheryl K Zogg, F Stephen Hodi, et al.
Melanoma Research|February 17, 2005
Melanoma of unknown primary: experience at Massachusetts General Hospital and Dana-Farber Cancer InstituteKenneth A Katz, Eric Jonasch, F Stephen Hodi, et al.
Cancer Immunology, Immunotherapy : CII|October 29, 2011
Immunity to the melanoma inhibitor of apoptosis protein (ML-IAP; livin) in patients with malignant melanomaJun Zhou, Noah K Yuen, Qian Zhan, et al.
Cancer Immunology Research|June 24, 2015
Radiographic Profiling of Immune-Related Adverse Events in Advanced Melanoma Patients Treated with IpilimumabSree Harsha Tirumani, Nikhil H Ramaiya, Abhishek Keraliya, et al.
Archives of Dermatology|June 12, 2002
Hypopigmentation associated with an adenovirus-mediated gp100/MART-1-transduced dendritic cell vaccine for metastatic melanomaHensin Tsao, Peri Millman, Gerald P Linette, et al.
Pageof 39